Judge blocks class certification against Takeda, Teva and others

A Pennsylvania federal judge has refused to certify a class of wholesale purchasers of a gout treatment medicine, finding that the claim against several major drugmakers is based on faulty expert testimony that does not hold up to rigorous analysis.

Unlock unlimited access to all Global Competition Review content